Diagnostic test maker Meridian Bioscience (NASDAQ:VIVO) has received regulatory clearance of a molecular diagnostics test for group B streptococcus. The group B strep test is the second in the ...

A clinical trial has shown that diagnostics company NanoLogix‘s (OTCBB: NNLX) rapid bacteria-detection test kits for Group B strep are, in fact, rapid. The trial at the University of Texas Health ...

Group B streptococcus (GBS) is a bacteria about 25% of pregnant women carry. It's rare for babies to get GBS disease from ...

A more rapid laboratory test for pregnant women to detect potentially deadly Group B strep (GBS) has been successful at identifying GBS colonization in six and a half hours, according to new results.

When Allison Walters* of New York City found out she had tested positive for group B streptococcus (GBS)—a common bacteria that can be transmitted to a baby during delivery and can result in serious ...

Many women are having different test results for Group B streptococcus between their routine third trimester screening and a rapid test performed at the time of labor. In a study presented February 11 ...

A new vaccine for Group B streptococcal bacteria in pregnant women is one step closer to arriving in doctors’ offices someday. Preliminary findings from a Phase 2 study found a vaccine covering three ...

The shares of Great Basin Scientific Inc (NASDAQ:GBSN) are trading 14.81% higher from their closing price yesterday as the company announced the commercial launch of its Group B Strep Test. The ...

The US Food and Drug Administration (FDA) has approved marketing clearance for the Alere i Strep A test (Alere Inc), the first molecular test that detects group A streptococcus bacteria in throat swab ...

Leading diagnostic test solutions provider Quidel Corporation ( QDEL) recently won the European CE Mark for its Sofia Streptococcus A ("Strep A") test for use with its Sofia Analyzer. The product is ...